Annovis Bio

Filed a patent for "treatment of mental illness via administration of buntanetap and analogues thereof" on Tue, January 24, 2023

Filed a patent for "treatment of mental illness via administration of buntanetap and analogues thereof" on Thu, August 1, 2024

Filed a patent for "inhibition of neurological injuries due to infections via administration of butanetap and analogs thereof" on Thu, November 24, 2022

Filed a patent for "(3ar)-1,3a,8-trimethyl-1 ,2,3,3a,8,8ahexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration" on Thu, October 13, 2022